Dow Up 0.00% Nasdaq Up 0.09%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.24 Down 0.02(1.59%) Nov 28, 1:04PM EST
Prev Close:1.26
Open:1.26
Bid:0.89 x 100
Ask:1.66 x 100
1y Target Est:4.31
Beta:1.61
Next Earnings Date:N/A
Day's Range:1.24 - 1.26
52wk Range:0.97 - 2.25
Volume:478,139
Avg Vol (3m):867,798
Market Cap:186.21M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 1.59%186.21M
LLYUp 1.19%72.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback